cefuroxime has been researched along with Eye Infections in 3 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
Eye Infections: Infection, moderate to severe, caused by bacteria, fungi, or viruses, which occurs either on the external surface of the eye or intraocularly with probable inflammation, visual impairment, or blindness.
Excerpt | Relevance | Reference |
---|---|---|
" Subsequent to the results of the European multicenter trial documenting decreased risk of endophthalmitis with intracameral cefuroxime injection at the end of surgery, similar benefit with intracameral antibiotic use has been reported in studies with large sample sizes from multiple centers around the world." | 4.89 | Role of topical, subconjunctival, intracameral, and irrigative antibiotics in cataract surgery. ( Basu, S; Vazirani, J, 2013) |
"In this retrospective, longitudinal study, the microbiology laboratory records of patients with different ocular infections diagnosed at an eye institute in central India from 2005-2020 were reviewed to determine the pattern of fluoroquinolone (ciprofloxacin, ofloxacin, gatifloxacin, and moxifloxacin) resistance." | 4.12 | Fluoroquinolone resistance in bacterial isolates from ocular infections: Trend in antibiotic susceptibility patterns between 2005-2020. ( Agrawal, D; Chatterjee, S; Gangwe, AB; Gomase, SN; Mishra, M; Parchand, SM, 2022) |
"The European Society of Cataract & Refractive Surgeons Endophthalmitis Study published preliminary results in 2006 showing a near 5-fold decrease in the rates of postoperative endophthalmitis with the use of intracameral cefuroxime." | 3.75 | United Kingdom survey of antibiotic prophylaxis practice after publication of the ESCRS Endophthalmitis Study. ( Angunawela, RI; Gore, DM; Little, BC, 2009) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Chatterjee, S | 3 |
Agrawal, D | 3 |
Gomase, SN | 3 |
Parchand, SM | 3 |
Gangwe, AB | 3 |
Mishra, M | 3 |
Gore, DM | 1 |
Angunawela, RI | 1 |
Little, BC | 1 |
Vazirani, J | 1 |
Basu, S | 1 |
1 review available for cefuroxime and Eye Infections
Article | Year |
---|---|
Role of topical, subconjunctival, intracameral, and irrigative antibiotics in cataract surgery.
Topics: Administration, Topical; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cataract Extraction; Cefurox | 2013 |
2 other studies available for cefuroxime and Eye Infections
Article | Year |
---|---|
Fluoroquinolone resistance in bacterial isolates from ocular infections: Trend in antibiotic susceptibility patterns between 2005-2020.
Topics: Anti-Bacterial Agents; Cefuroxime; Ciprofloxacin; Colistin; Eye Infections; Fluoroquinolones; Gatifl | 2022 |
Fluoroquinolone resistance in bacterial isolates from ocular infections: Trend in antibiotic susceptibility patterns between 2005-2020.
Topics: Anti-Bacterial Agents; Cefuroxime; Ciprofloxacin; Colistin; Eye Infections; Fluoroquinolones; Gatifl | 2022 |
Fluoroquinolone resistance in bacterial isolates from ocular infections: Trend in antibiotic susceptibility patterns between 2005-2020.
Topics: Anti-Bacterial Agents; Cefuroxime; Ciprofloxacin; Colistin; Eye Infections; Fluoroquinolones; Gatifl | 2022 |
Fluoroquinolone resistance in bacterial isolates from ocular infections: Trend in antibiotic susceptibility patterns between 2005-2020.
Topics: Anti-Bacterial Agents; Cefuroxime; Ciprofloxacin; Colistin; Eye Infections; Fluoroquinolones; Gatifl | 2022 |
United Kingdom survey of antibiotic prophylaxis practice after publication of the ESCRS Endophthalmitis Study.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Endophthalmitis; Eye Infections; Guidelin | 2009 |